Equity Profile
Post-Earnings Recap
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.08 | N/A | +60.00% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.08 | N/A | +60.00% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting their commitment to product expansion. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on expanding our product offerings.
Lemaitre Vascular's strong EPS performance exceeded expectations, driving a positive stock reaction of 2.08%. The company did not disclose revenue figures or future guidance, which leaves some uncertainty for investors. Overall, the positive EPS surprise reflects effective cost management and operational efficiency.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
LABCORP HLDGS INC